Posts
Digital Breast Tomosynthesis (DBT) Equipment is a product
developed by a team of breast augmentation doctors and technicians, with an aim
to provide patients with one of the most reliable, safest, and cost-effective
procedures available. As this revolutionary new breast enhancement procedure is
not available in every area, it can be hard to find the correct equipment to
suit your specific needs. Digital breast
tomosynthesis equipment is designed to provide all-over improvement to the
breasts so that any woman can get the look she wants without incurring
outrageous costs. DBT also referred to as 3D mammography, is also used by
radiologists to diagnose breast cancer. It uses a series of two-dimensional
images to build a 3D image of the breast.
Increasing prevalence of breast cancer is expected to drive growth
of the global digital breast tomosynthesis equipment market during the forecast
period. According to the World Cancer Research Fund, in 2018, there were over 2
million new cases of breast cancer across 25 countries in the world. According
to the American Cancer Society, in 2020, around 276,480 new cases of invasive
breast cancer are expected to be diagnosed in the U.S. in women with over
40,000 women dying from it. Such a massive prevalence of breast cancer has
increased the demand for DBT equipment across the globe. Thus, these factors
are expected to drive growth of the global digital
breast tomosynthesis equipment market during the forecast period.
Furthermore, rising awareness regarding the use of DBT equipment as well as
technological advancements in the field of breast imaging is expected to propel
the global digital breast tomosynthesis equipment market growth in the near
future.
However, the high capital cost of the equipment combined with
side-effects related to radiation exposure is expected to restrict growth of
the global digital breast tomosynthesis equipment market during the forecast
period. Furthermore, among regions, North America is expected to witness
significant growth in the global digital breast tomosynthesis equipment market
during the forecast period. This is owing to high demand for innovative
products as well as the presence of skilled healthcare professionals in the
region.
Key players involved in the global digital breast tomosynthesis
equipment market are Hologic, Inc., Trivitron Healthcare, GE Healthcare,
Analogic Corporation, Fujifilm Holdings Corporation, Planmed Oy, Siemens
Healthineers, and General Medical Merate SpA.
For instance, in March 2020, Hologic Inc., a U.S.-based medical
technology company, received the U.S. Food and Drug Administration (FDA)
approval for its 3DQuorum Imaging Technology, which is powered by Genius AI.
No comments:
Post a Comment